Cardiovascular Protective Effect of Spironolactone in Hemodialysis

NCT00277693 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Hemodialysis

Interventions

DRUG: Spironolactone (drug)

Sponsor

Universidad de los Andes, Chile